Developed in conjunction with

October, 2014
SOM Biotech will attend next BIO-Europe
September, 2014

SOM Biotech announces the appointment of Mr.

September, 2012

A recent Thomson Reuters report indicates that drug repositioning is expected to generate up to $20Billion in annual sales during 2012, thus opening up a new source of revenue to large, medium and small Pharma companies.